HSC Participating in National Study of Potential New Treatment for Parkinson's Disease
The UNM Health Sciences Center Participating People in the Albuquerque-area living with advanced Parkinson's disease can participate in a clinical trial that is testing an investigational drug.
Paul H. Gordon, M.D., assistant professor, Neurology and director of the Neuromuscular and Movement Disorder Programs at the University of New Mexico Health Sciences Center, is principal investigator in Albuquerque for a study that is recruiting people with advanced Parkinson's disease who are taking levodopa. Potential participants must have frequent periods of movement difficulty or must no longer have a consistent response to their current Parkinson's medication.
Approximately 1 million Americans are living with Parkinson's disease. Individuals with advanced Parkinson's disease experience unpredictable responses to their medication, making it difficult to plan and perform daily activities. The current study, entitled the PRESTO Study, will determine if rasagiline mesylate can provide relief of symptoms when added to a levodopa regime.
The trial will last approximately six months and involve between 40 and 60 study sites throughout North America. To be considered for the PRESTO trial in the Albuquerque-area, people with advanced Parkinson's disease or their loved ones should call toll free 1-888-887-3PSG (3774).
Contact: Cindy Foster, 272-3322